Reagent Kit for ELISA Detection of IgG Antibodies to the Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Glycoprotein "SARS-CoV-2-RBD-ELISA-Gamaleya"

Reagent Kit for ELISA Detection of IgG Antibodies to the Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Glycoprotein "SARS-CoV-2-RBD-ELISA-Gamaleya"

The reagent kit "SARS-CoV-2-RBD-ELISA-Gamaleya" is intended for enzyme-linked immunosorbent assay (ELISA) detection of IgG antibodies to the receptor-binding domain (RBD) of the SARS-CoV-2 surface spike glycoprotein, according to TU 21.20.23-090-01894956-2020.

Kit Contents:

• ELISA plate with immobilized recombinant RBD of SARS-CoV-2 spike glycoprotein ("Immunosorbent") – 1 unit
• Positive control (K+), inactivated, 0.5 ml – 1 tube
• Negative control (K−), inactivated, 0.5 ml – 1 tube
• Conjugate (20× concentrate), 0.5 ml – 1 tube
• Washing buffer concentrate (PBS-T) (25×), 20 ml – 1 bottle
• Dilution buffer, 20 ml – 1 bottle
• Chromogen solution, 10 ml – 1 bottle
• Substrate solution, 2 ml – 1 bottle
• Stop reagent, 20 ml – 1 bottle
• Plate sealing film – 1 piece
• Instructions for use – 1 copy
• Batch certificate – 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for ELISA Detection of IgG Antibodies to the Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Glycoprotein "SARS-CoV-2-RBD-ELISA-Gamaleya", then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.